EU competition authorities to rule on Novo’s purchase of Catalent by 6 December
EU competition authorities will decide by 6 December whether to approve Novo Holdings’ acquisition of contract drugmaker Catalent, the European Commission said in a document published on its website on Monday.
BELIEBTE BEITRÄGE
Spain’s vice-president Ribera blames floods on climate change
November 22, 2024
Storm lashes northwestern US, killing two people
November 22, 2024
Iceland volcano erupts for tenth time in three years
November 22, 2024
A banana wrapped in duct tape sells for $6.2 million at auction
November 22, 2024
LIVEÜBERTRAGUNG